Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruddy

Showing results (351-360 of 399) with videos related to

Pageof 40
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 27, 2023
Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported OutcomesRobert W Gao, Trey C Mullikin, Khaled A Aziz, et al.
Current Epidemiology Reports|September 13, 2023
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young AdultsHazel B Nichols, Karen J Wernli, Neetu Chawla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline UpdateBeverly Moy, R Bryan Rumble, Steven E Come, et al.
The Oncologist|June 13, 2023
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG)Carolien P Schröder, Elise van Leeuwen-Stok, Fatima Cardoso, et al.
Breast Cancer Research : BCR|July 12, 2022
Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligenceJoshua Ogony, Thomas de Bel, Derek C Radisky, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast CancerMatteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
The Lancet. Oncology|September 11, 2023
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trialRobert W Mutter, Sharmila Giri, Briant F Fruth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
JAMA Oncology|January 28, 2021
Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus StatementRachel A Freedman, Christina A Minami, Eric P Winer, et al.
Pageof 40

Showing results (351-360 of 399) with videos related to

Sort By:
Pageof 40
International Journal of Radiation Oncology, Biology, Physics|May 27, 2023
Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported OutcomesRobert W Gao, Trey C Mullikin, Khaled A Aziz, et al.
Current Epidemiology Reports|September 13, 2023
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young AdultsHazel B Nichols, Karen J Wernli, Neetu Chawla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline UpdateBeverly Moy, R Bryan Rumble, Steven E Come, et al.
The Oncologist|June 13, 2023
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG)Carolien P Schröder, Elise van Leeuwen-Stok, Fatima Cardoso, et al.
Breast Cancer Research : BCR|July 12, 2022
Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligenceJoshua Ogony, Thomas de Bel, Derek C Radisky, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast CancerMatteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
The Lancet. Oncology|September 11, 2023
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trialRobert W Mutter, Sharmila Giri, Briant F Fruth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
JAMA Oncology|January 28, 2021
Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus StatementRachel A Freedman, Christina A Minami, Eric P Winer, et al.
Pageof 40